| CAS: | 572-03-2 | |
| 分子式: | C25H24O6 | |
| 分子量: | 420.45 | |
| 英文名称: |
| |
| 用途: | Pomiferin, a flavonoid from the fruits of Maclura pomifera, acts as an potential inhibitor of HDAC, with an IC50 of 1.05 μM, and also potently inhibits mTOR (IC50, 6.2 µM). |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||
| P912565 | MACKLIN | 橙桑黄酮 | 98% | 9033元/5mg; | 咨询 | ||||||||||||||||||||||
储存:-20°C,密闭,干燥 | |||||||||||||||||||||||||||
| SMB01027 | Sigma-Aldrich | Pomiferin | ≥90% (LC/MS-ELSD) | 4332元/1 MG; | 咨询 | ||||||||||||||||||||||
产品说明 一般描述 Pomiferin is a flavonoid. 生化/生理作用 Pomiferin acts as an potential inhibitor of HDAC, with an IC50 of 1.05 μM, and also potently inhibits mTOR (IC50, 6.2 μM). Pomiferin shows cytotoxic effects on human tumor cell lines. Pomiferin also increases SOD activities and total antioxidative capacity, and decreases malondialdehyde in rats. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||
| HY-N4315 | MCE | Pomiferin,572-03-2,橙桑黄酮_MCE(MedChemExpress) | 2100元/1 mg; 5320元/5 mg; | 咨询 | |||||||||||||||||||||||
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 PomiferinMCE 国际站:Pomiferin 品牌:MedChemExpress (MCE) 货号:HY-N4315 CAS 号:572-03-2 生物活性:Pomiferin (NSC 5113) 是一种潜在的 HDAC 抑制剂,IC50 为 1.05 μM,并且能有效抑制 mTOR (IC50 为 6.2 µM)。 体外研究(In Vitro):Pomiferin is an potential inhibitor of HDAC, with an IC50 of 1.05 μM. Pomiferin shows cytotoxic effects on human tumor cell lines, with GI50s of 1.32 ± 0.02 μM (HCT-15 cells), 2.92 ± 0.09 μM (MDA-MB-231 cells), 3.18 ± 0.05 μM (ACHN cells), 3.34 ± 0.11 μM (LOX-IMVI cells), 3.95 ± 0.05 μM (PC-3 cells), 5.14 ± 0.06 μM (NCI-H23 cells), and 123 μM (Hepatocyte cells)[1]. Pomiferin is a highly specific mTOR inhibitor, with an IC50 of 6.2 µM. Pomiferin triacetate only affects two PI3Kα mutants, E542K and E545K. Pomiferin triacetate (0.3125-20 µM) stabilizes Pdcd4 from TPA-induced degradation in HEK293 cells. Pomiferin triacetate (20 µM) inhibits IGF-1-induced signaling downstream of Akt activation[2]. MCE尚未独立确认这些方法的准确性。 仅供参考。 体内研究(In Vivo):Pomiferin (5, 10 and 20 mg/kg, p.o.) shows protective effects on the treatment of reperfusion injury. Pomiferin also increases SOD activities and total antioxidative capacity, and decreases malondialdehyde in rats[3]. MCE尚未独立确认这些方法的准确性。 仅供参考。 分子量:420.45 Formula:C25H24O6 性状:固体 颜色:Light yellow to yellow 中文名称:橙桑黄酮 运输条件:美国大陆地区的室温;其他地区可能有所不同。 储存方式:粉末 -20°C 3年 Cell Assay [1]:从ATCC购买的细胞系培养于添加10%马血清和5%胎牛血清的Dulbecco改良Eagle培养基(DMEM)中,并在37℃、5% CO₂培养箱中培养。细胞经PBS洗涤三次以去除血清,并重悬于DMEM中。将悬浮的细胞接种于96孔板(1 × 10⁴个细胞/孔),并用Pomiferin处理。处理21小时后,向培养基中加入MTT(0.5 mg/mL),并在37℃下继续孵育3小时。弃去培养基后,向孔中加入DMSO(100 mL)以溶解甲臜晶体,并在酶标仪上测量各孔在570 nm和630 nm处的吸光度[1]。MCE尚未独立确认这些方法的准确性。仅供参考。 Animal Administration [3]:Rats[3] Male Wistar SPF laboratory rats are used in the study. After 10 days of acclimation, 50 animals are randomised in 5 groups (n=10). One group is left intact. Four groups undergo laparotomy in general anaesthesia (2% Rometar (xylazine) 0.5 mL + Narkamon (ketamine) 10 mL, dose 0.5 mL solution /100 g of body mass). Ischaemia-reperfusion injury is induced by applying a vascular clamp on the left renal artery for 60 min with subsequent renal reperfusion. Each animal (including those of the intact group) is put into its own metabolic cage. For 15 days all the animals are bred in these cages. The doses of pomiferin are suspended in 2 mL of 0.5% Avicel solution (microcrystalline cellulose) and are administered starting with day 1 after operation. Three of four operated groups are medicated with Pomiferin-orally by gastric gavage once a day in different doses: 5 mg/kg, 10 mg/kg and 20 mg/kg. The placebo group is given 2 mL of 0.5% Avicel by the same route. On day 15, all the animals are exsanguinated in general anaesthesia (2% Rometar 0.5 mL + Narkamon 10 mL, dose 0.5 mL solution /100 g of the rat body mass) by blood collection from the left ventricle and the reperfused kidney tissue is employed for histopathological examination[3]. MCE尚未独立确认这些方法的准确性。 仅供参考。 文献引用:MCE 顾客使用本产品发表 1 篇科研文献 提供质量检测报告:Data Sheet、SDS、COA、产品使用指南 产品活性:Pomiferin (NSC 5113) 为 HDAC 和 mTOR 的抑制剂,IC50 值分别为 1.05 μM 和 6.2 µM。 相关产品:Trichostatin A | Y-27632 | Laduviglusib | Laduviglusib | Laduviglusib (Standard) | PEG300 | Y-27632 (Standard) | PEG400 | PEG100000 | PEG1000000 | PEG200000 | PEG5000000 热门产品线:抑制剂 | 稳定性同位素标记物 | 脂质 | 糖类 Trending products:Inhibitors | Isotope-Labeled Compounds | Lipids | Saccharides MCE 抑制剂: MedChemExpress 信号通路产品覆盖细胞凋亡、自噬、细胞周期与 DNA 损伤、表观遗传、GPCR/G 蛋白、免疫与炎症、JAK/STAT、MAPK/ERK、膜转运体与离子通道、代谢酶与蛋白酶、神经信号、NF-κB、PI3K/Akt/mTOR、PROTAC、蛋白酪氨酸激酶/受体酪氨酸激酶、干细胞/Wnt、TGF-β/Smad 及维生素 D/核受体等研究方向,为肿瘤、感染、炎症与免疫、神经系统疾病、代谢性疾病、心血管疾病和内分泌研究提供多维度的产品选择,助力客户发表文献超 80,000 篇。 相关产品可根据具体情况提供化学结构、作用靶点、生物活性、纯度、溶解度、体内外研究信息、参考文献及质量分析报告 (COA)等资料。 客户发表文献: 参考文献: 品牌介绍:
| |||||||||||||||||||||||||||